Series A · Biotech
Infinimmune: Series A
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Funding history
Series A · This round$75M
Loading rounds…
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease